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A New Determinant of Glucocorticoid 
in Lymphoid Cell Lines 
Sensitivity 
JUDITH C. GASSON and SUZANNE BOURGEOIS 
The Salk Institute for Biological Studies, Regulatory Biology Laboratory, San Diego, California 92138 
ABSTRACT The SAK cell line, derived from a spontaneous thymic lymphoma in an AKR mouse, 
is resistant to lysis by glucocorticoids in spite of the presence of functional glucocorticoicl 
receptor. Receptor function was determined by hormone binding analyses, as well as charac- 
terization of hormonal effects on cell growth and on the accumulation of murine leukemia 
virus and metallothionein mRNAs. SAK cells were fused with a receptor-defective (and 
therefore resistant) variant of a well-characterized murine thymoma line, W7. The resulting 
hybrids are glucocorticoid sensitive, demonstrating complementation of the receptor defect in 
W7 cells by the functional glucocorticoid receptor of SAK. This fusion shows that SAK cells are 
resistant to the hormone clue to the absence of another function designated 'T' for lysis. SAK 
cells were also fused with glucocorticoid-sensitive W7 cells (containing wild-type receptor), 
generating glucocorticoid-sensitive hybrids, which demonstrate that the dexamethasone-re- 
sistant phenotype of the SAK cells is recessive. Resistant derivatives of this hybrid were found 
which still contain the full amount of receptor. Chromosome analysis revealed that, on the 
average, the resistant derivatives had lost two chromosomes, suggesting segregation of chro- 
mosomes carrying genetic material necessary for the "lysis" function. 
The drug 5-azacytidine (a known inhibitor of DNA methylation) has been shown to cause 
heritable changes in gene expression. Treatment of SAK cells with 5-azacytidine generated 
glucocorticoid-sensitive clones at high frequency, suggesting that the gene(s) involved in the 
"lysis" function are intact and have been inactivated through a process such as differentiation. 
It has been known for over thirty years that T-lymphocytes, 
during early stages of differentiation, are lysed by glucocorti- 
coid hormones. In addition, a number of neoplastic T-cell lines 
derived from both human (1) and mouse (2, 3) are sensitive to 
lysis by glucocorticoids (1--4). A variety of mutagenic treat- 
ments have been used to generate dexamethasone- (dex, a 
synthetic glucocorticoid) resistant derivatives ofglucocorticoid- 
sensitive lymphoid cell lines in order to study the biology of 
the lytic response, as well as the mechanism of action of 
glucocorticoids. Numerous tudies have demonstrated that glu- 
cocorticoid receptor binding and translocation of the steroid 
hormone into the nucleus are a necessary step for the response; 
further steps in the cytolytic pathway remain obscure (reviewed 
in references 5-7). In spite of considerable effort, no resistant 
variant resulting from a defect in a function other than the 
receptor has ever been found (8, 9). Moreover, complementa- 
tion between receptor-defective variants has never been ob- 
served (8, 10), indicating that all variants obtained so far result 
from defects in the same genetic locus. 
SAK is a cell line derived from a spontaneous thymic 
lymphoma in an AKR/J  mouse. SAK cells do not lyse in 
response to dex; instead, the cells continue to grow and also 
form aggregates. This report provides both biological and 
biochemical evidence that the glucocorticoid receptor in SAK 
cells is functional. The presence of functional glucocorticoid 
receptor in this dex-resistant T-ceU line makes it possible to 
use a genetic approach to begin to analyze other steps in the 
cytolytic pathway. Genetic experiments are described which 
show that at least one other function, in addition to hormone 
binding to the receptor, is required for the cytolytic response to 
glucocorticoids. Treatment of SAK cells with 5-azacytidine (an 
inhibitor of DNA methylation) causes this "lysis" function to 
be activated and results in a cytolytic response to glucocorti- 
coids. Our results support the hypothesis that this "lysis" 
function is inactivated in SAK cells possibly as a result of 
differentiation. Thus, SAK cells may provide a model for a 
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more differentiated ex-resistant T-cell and provide insights 
into this mode of acquisition of glucocorticoid resistance in 
vivo. 
MATERIALS AND METHODS 
Cell Lines and Culture Conditions: The SAK cell line 
(SAKRTLS.12.1) is a cloned routine T-cell line derived from a spontaneous 
tumor in an AKR mouse. The SAK cells were a generous gift from Dr. Robert 
Hyman (Salk Institute). Both SAK and its subclone, SAK8, show the same 
properties with respect o glucocorticoid receptor and response. The receptor- 
defective W7 variant used is Mouarl01a derived by M. Huet-Minkowski (Institut 
Pasteur) by treatment ofW7TG with bleomycin to produce a receptorless variant 
which was then selected for ouabain resistance (8). This variant has been shown 
by Scatchard analysis to contain <10% of the amount of specific binding seen in 
the parent (data not shown) and is completely resistant to lysis. The W7 line 
containing two copies of the wild-type receptor locus, which was used in this 
work, is W7TGoua r~ isolated by M. Pfahl (Salk Institute; l 1). All cell lines and 
hybrids were grown in Dulbecco's Modified Eagle's medium (DME) containing 
10% fetal calf serum (FCS) in a humidified atmosphere at37°C. 
Steroid Binding Assays: The binding of [3H]dex to whole cells and 
the nuclear transfer of the receptor-hormone complex were measured as described 
(12). 
Analysis of mRNA Accumulation: The accumulation f leukemia 
virus mRNA in SAK8 cells was measured by the method of Wahl et al. (13). 
Briefly, oligo(dT) cellulose columns were used to select poly(A)-containing 
mRNA. The mRNA was denatured with glyoxal, fractionated in a 1% agarose 
gel, transferred tonitrocellulose paper, and probed with Moloney leukemia virus 
cDNA (generously provided by Dr. Inder Verma, Sulk Institute). The nitrocel- 
lulose was washed and exposed to film. The developed film was analyzed by 
scanning the bands which correspond to viral mRNA in an LKB densitometer 
(LKB Instruments, Broma, Sweden). The area under the peaks was compared to 
quantitate the increase in viral mRNA. 
Cell Fusions and Chromosome Analysis: Cell fusions were 
induced by polyethylene glycol and carried out essentially as described by 
Davidson and Gerald (14). The W7 derivatives both carried a selectable marker 
(resistance to 6 thioguanine or bromodeoxyuridine) as well as resistance to 1-5 
mM ouabain. Hybrids were selected in HAT medium (15) containing 1 mM 
ouahain. The DNA content of the hybrids was analyzed on the flow microfluor- 
imeter after staining the cells with chromomycin (16). 
The number of chromosomes in the hybrid clones was determined asdescribed 
previously (4). 
5-Azacytidine Treatment: Exponentially growing SAK8 cells were 
treated for 13 h with 3 #M 5-azacytidine (Calhiochem-Behring Corp., San Diego, 
CA). After extensive washing, the cells were allowed to recover until exponential 
growth had resumed (24-48 h), then subcloned at a dilution of 0.25 cells/well in 
tissue culture trays. Clones were picked 9 d later and screened for dex sensitivity. 
The cloning efficiency of the 5-azacytidine-treated cells is 30%-50%; the cloning 
efficiency of untreated ceils is 100%. 
RESULTS 
Growth of SAK8 Cells in the Presence of Dex 
SAK8 cells normally grow in suspension as single cells or 
small clumps of three to eight cells (Fig. IA). After 48 h of 
culture in medium containing 5 x 10 -a M dexamethasone, the 
cells do not lyse; instead, large aggregates of up to 100 cells 
appear (Fig. 1 B). Such aggregates of cells are also seen in the 
presence of other glucocorticoid hormones such as cortisol 
(data not shown). If the formation of the aggregates i  specific 
for glucocorticoid hormones, it should be possible to prevent 
the response by adding an excess of an antiglucocorticoid 
compound. In the presence of 5 x 10 -6 M progesterone alone, 
a known antiglucocorticoid (17), the gross phenotypic harac- 
FIGURE I Growth of SAK8 cells in the absence and presence of hormone. SAK8 cells were cultured as described in Materials and 
Methods for 4 d in the absence (A) or presence of the fo l lowing hormones: (B) 5 x 10 -a M dexamethasone, (C) 5 x 10 6 M 
progesterone, (D) 5 x 10 6 M progesterone, and 5 x 10 -a M dexamethasone. Magnif ications are the same in A-D. 
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teristics of the cells remain unchanged (Fig. 1 C). Fig. 1 D 
shows that a 100-fold excess of progesterone (5 × 10 -6 M) does 
in fact block the aggregation response to dex (5 x 10 -a M). 
In addition to the aggregation response, SAK8 cells grow 
more slowly in the presence of dex. The doubling time is 
increased from 12 h to ~18 h and the cultures reach a final cell 
density of 1 to 1.5 x 106 cells/ml rather than 2.5 to 3.5 × 106 
ceUs/ml (refer to Fig. 7A). The ability of single cells to form 
clones is also decreased from 100% seen in the absence of 
hormone to between 20% and 50% in 10 -6 M dex. This inhi- 
bition in cloning efficiency is overcome by increasing the FCS 
from 10% to 20%, conditions in which the cloning efficiency 
increases to between 70% and 100% of the control. These 
hormonal effects on cell doubling time and cloning efficiency 
could result from a decrease ingrowth factor production caused 
by glucocorticoid hormones. Such an effect on growth factor 
production has been described in mitogen-induced T-cells 
where clonal expansion is inhibited by dex (18). 
These effects of dex on the grwoth of SAK8 cells indicate 
that, in spite of the absence of the cytolytic response, glucocor- 
ticoid hormones have specific effects mediated by functional 
glucocorticoid receptor. To confirm this observation, we turned 
to other, more biochemical approaches, to demonstrate func- 
tional hormone receptor in these cells. 
Glucocorticoid Receptor in SAK Cel l s  
Fig. 2 shows the Scatchard analysis (19) of [3H]dex-binding 
data from SAK cells and several hybrids generated from SAK 
(described in following sections). SAK cells contain approxi- 
mately 31,000 (mean + SE = 30,700 _ 2,800) glucocorticoid- 
binding sites per cell, with a dissociation constant of 10 nM for 
dex. In addition, nuclear transfer assays how that >60% of the 
receptor-hormone complexes are translocated into the nucleus 
(data not shown). The results of the Scatchard and nuclear 
transfer analyses are very similar to the values obtained for the 
WEHI-7 (WT) cell line (4) and another AKR cell line (unpub- 
lished observations), both of which are lysed by dex. The 
hormone binding analyses used here have detected alterations 
in receptor number or nuclear transfer capacity of hundreds of 
W7 variant clones (8, 9) which are resistant o dex due to 
receptor defects. Thus, abnormal binding of glucocorticoid 
hormone in SAK cells would be detectable by these procedures. 
Increased Accumulation of Specific mRNAs in 
the Presence of Dex 
The SAK8 cell line was derived from a spontaneous thymic 
lymphoma in an AKR/ J  mouse. AKR/ J  mice have stably 
integrated copies of murine leukemia virus (type C retrovirus) 
in their genome. Glucocorticoid hormones have been reported 
to enhance the synthesis of virus in an AKR mouse embryonic 
cell line (20) and other cell lines which express type C retrovi- 
ruses (21, 22). Thus, it was of interest to determine whether the 
endogenous murine leukemia virus (MuLV) mRNA in SAK8 
cells was increased by dex, especially in view of the fact that 
we had seen an increase in synthesis of the viral gp70 envelope 
glycoprotein (23). 
RNA was prepared from SAK8 cells incubated in medium 
containing 10 -7 dex for 6 or 24 h. Poly(A)-containing RNA 
was selected using oligo(dT) cellulose. Samples of untreated 
control mRNA as well as mRNA from dex-treated cells were 
fractionated in an agarose gel, transferred to nitrocellulose 
paper, and the transfer was probed with Moloney leukemia 
virus cDNA. The hybridized blot was exposed to film, and the 
densitometric s an of the film was analyzed. Table I shows that 
the samples from the cells treated with dex for 6 or 24 h contain 
over threefold more mRNA that hybridized to the leukemia 
virus cDNA probe than the control. 
Work by Palmiter et al. (24) has shown that glucocorticoid 
hormones increase the levels of metailothionein mRNA in a 
variety of cell types. Metallothionein mRNA was quantitated 
by solution hybridization (25) using nucleic acids extracted 
from untreated SAK8 cells and those grown in the presence of 
10 -6 M dex for 20 h. Table I shows a 2.5-fold increase in 
metallothionein mRNA molecules/ceil after dex treatment. 
This induction is similar to that obtained in W7 cells after 
demethylation f the metallothionein gene by treatment of W7 
cells with 5-azacytidine (26). The metallothionein gene is not 
expressed in W7 cells before treatment with 5-azacytidine. 
We have shown that both MuLV mRNA and metailothi- 
onein mRNA levels are increased in SAK8 cells treated with 
dex. These results together with the effects of glucocorticoids 
on SAK8 growth and the dex binding assays leave little doubt 
that SAK8 ceils contain functional glucocorticoid receptor. 
Therefore, SAK ceils must be resistant to lysis by glucocorticoid 
hormones because they lack another function involved in the 
cytolytic response. We have used a genetic approach to address 
the basis for glucocorticoid resistance in these cells. 
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FIGURE 2 Binding of [3H]dex to SAK cells and hybrids. The whole 
cell-binding assays were performed as described (12) and the data 
was analyzed by the method of Scatchard (19). The data shown are 
those of one representative analysis. The mean number of receptor 
sites and standard error calculated from at least three independent 
assays are given in the text: SAK parent (A); hybrid between SAK 
cells and the receptor-defective variant of W7 (0); hybrid between 
SAK cells and the W7 parent containing wild type receptor (x); 
resistant derivative of this hybrid (O). In all cases the dissociation 
constant for dex was -10  nM. 
TABL[ I 
Effect of  Dex on Specific mRNA Levels 
Concentra- Dex- 
tion of dex Time No dex treated 
M h 
MuLV 10 -7 6 1" 3.3 
24 1 3.2 
Metallothionein 10 -6 20 905 224 
PolyA ÷ RNA was prepared and MuLV mRNA analyzed as described in 
Materials and Methods. Metallothionein mRNA was assayed by R. Palmiter 
as described (personal communication; 25). 
* Relative units as derived from densitometer tracings of film exposed to 
Northern blot (see Materials and Methods). 
I: Units are molecules per cell. 
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Genetic Complementation 
To demonstrate he existence of another function involved 
in the cytolytic response, we fused SAK cells with a receptor- 
defective variant of the dex-sensitive W7 cell line. Fig. 2 shows 
the Scatchard analysis of the [3H]dex-binding data from this 
hybrid. The hybrid contains essentially the same number of 
sites (27,100 + 1,800) with the same affinity for hormone as 
the SAK parent. This is the expected result since nearly all of 
the dex binding sites in the hybrid are contributed by the SAK 
cells. After fusion, no appearance of previously unexpressed 
hormone binding sites contributed by the W7 parent is seen. 
Fig. 3 shows the growth of the two parental cell lines and 
four hybrid clones in varying concentrations of dex. Both the 
parental lines and hybrid clones grow in the absence of hor- 
mone (top row), but only the two dex-resistant parental lines 
grow in the presence of dex (10 -~ to 10 -6 M). The $AK line 
appears to have fewer cells in the presence of dex, due to cell 
aggregation and the decreased t'mal cell density described 
above. The small white areas seen in the wells containing the 
hybrids in the presence of dex are cell debris. 
Fig. 4 shows growth curves of the SAK parent, the receptor- 
defective W7 parent and one of the hybrid clones in 10 -5 M 
dex. It is evident from the growth curve that the hybrid clone 
is killed by dex while the two parental cell lines continue to 
grow. Direct microscopic observation showed that all seven 
hybrids derived from this fusion were lysed by alex. 
Since the defect conferring resistance to the W7 derivative is 
known to be the absence ofglucocorticoid receptors (< 10% of 
the wild-type receptor number), the observed complementation 
(Figs. 3 and 4) demonstrates that the SAK line is resistant to 
lysis by dex because it lacks a function other than the receptor, 
designated "1" for lysis. The lysis function in the hybrid is 
contributed by the receptor-defective W7 variant, and func- 
tional receptor is contributed by the SAK parent. This comple- 
mentation can be expressed in the following simplified way: 
SAK (2r+/21 -) × W7 (2r-/21 +) ~ hybrid (2r+2r-/21+21-). 
dex-resistant dex-resistant dex-sensitive 
FIGURE 4 Kinetics of  lysis 
in a hybrid" cell line. 
Growth curves were per- ,J io 6 
formed in the presence of  ~, 
I0 -s M dex on the SAK (X) ,~ s 
and receptor-defective W7 
(Ix) parents and one of  the .~ 
.3 hybrids (©) shown in Fig. a 
3. Living cells were deter- 
mined by trypan blue ex- 
clusion and counted in a i°~ 
hemocytometer.  
~4 48 72 96 
HOURS 
FIGURE 3 Complementat ion between two dex r cell lines. Parental cell lines (SAK and W7) and four  independent ly  arisen hybrids 
were inoculated into a 24-well tissue culture tray at a cell density of  I0 s cells/ml. The molar concentrat ion of  dex is indicated for 
each row. The cells were al lowed to grow for 4 d before the tray was photographed.  The whi te  areas are generated by the presence 
of  cells or cellular debris. 
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In this diagram, r + indicates the presence of a functional 
receptor locus and 1 + indicates the presence of the lysis function 
which may be encoded by one or several loci. 
Segregation of the Lysis Function 
Since intraspecies hybrids have been shown to segregate 
chromosomes (10, 27, 28), we wished to obtain hybrid deriva- 
tives which had become dex resistant through the loss of the 
'T' function, while retaining the full amount of receptor. We 
constructed another type of hybrid containing four copies of 
the glucocorticoid receptor, but only two copies of the func- 
tional "lysis" locus or loci, in order to favor segregation of the 
"l" function. We fused SAK cells with dex-sensitive W7 cells 
which contain 30,000 glucooorticoid receptors per cell to pro- 
duce hybrids tetraploid for the receptor. All six hybrids tested 
had between 50,000 and 60,000 receptors per cell. One hybrid 
with 50,900 (+3,600) receptors per cell (Fig. 2) was used for 
further studies. The number of receptor sites should approach 
60,000 sites/cell (the sum of the receptor contents of SAK and 
W7). However, previous reports have shown that in parental 
fusions between W7 lines, some variability in the number of 
receptor sites of hybrid clones is seen (10, 29). This appears to 
be due to random segregation of chromosomes. The karyotype 
that the hybrids produced by the fusion of SAK with dex- 
sensitive W7 cells (Fig. 6A) shows many cells with fewer than 
the modal number of chromosomes. The hybrids obtained 
from this fusion are sensitive to dex. The fusion can be de- 
scribed as: 
SAK (2r+/21 -) × W7 (2r+/21 +) ~ hybrid (4r+/21+21-). 
alex-resistant dex-sensitive dex-sensitive 
The fact that dex-sensitive hybrids are generated from the 
fusion of a dex-sensitive parent with a alex-resistant parent 
indicates that the dex-resistant phenotype is recessive. This 
supports the hypothesis that the SAK cells are resistant to dex 
because of the absence of the lysis function and not due to the 
presence of a "protecting" substance. 
Dex-resistant derivatives of the hybrid containing four copies 
of the receptor allele were selected at a frequency on the order 
of 2.5 x 10 -5. Of the six dex-resistant derivatives tested, four 
retained the full amount (50,000 to 60,000 sites per cell) of 
glucocorticoid receptor; in all cases, the nuclear transfer of the 
receptor was essentially the same as that of the dex-sensitive 
hybrid parent. 
Fig. 5 shows the growth of the dex-sensitive hybrid, which 
is killed in 10 -'~ M dex, and of one dex-resistant derivative. The 
resistant derivative which still contains 50,900 (+_ 4,300) recep- 
tors/cell (Fig. 2) continues to grow in the presence of the 
hormone. Since chromosome segregation would provide a 
likely explanation for the appearance of dex-resistant deriva- 
tives from the dex-sensitive phenotype, we determined the 
number of chromosomes in the dex-sensitive hybrid and its 
dex-resistant derivative. 
The modal number of chromosomes in the dex-sensitive 
hybrid is 80 (Fig. 6A). In the dex-resistant derivative (shown 
in Fig. 5) the modal number of chromosomes has shifted to 78 
(Fig. 6 B). This result is consistent with the idea that the dex- 
resistant derivative has segregated two chromosomes which 
carry the genetic information for the "lysis" function involved 
in the response: 
Previous work has shown that fusion of two wild type W7 
parents yielding a hybrid with four copies of the receptor locus 
gave rise to dex-resistant variants with a frequency of <2.5 x 
10 -s (28). This low t;requency is expected since this hybrid 
would also have four copies of the lysis function. 
In other experiments, dex-resistant derivatives were selected 
using the hybrid which only contains two receptor alleles. In 
this case, segregation fchromosomes carrying enetic material 
involved in the "lysis" function is not favored (2r+2r-/21+21 -) 
over segregation of chromosomes bearing receptor loci. Pre- 
dictably, 18 out of 21 clones analyzed had -<50% of the hor- 
mone binding seen in the dex-sensitive hybrid parent. Such 
dex-resistant clones arose at a frequency on the order of 5 x 
10 -3 , two orders of magnitude higher than the frequency of 
resistance derived from the hybrid tetraploid for the receptor. 
These results are in good agreement with previous tudies using 
hybrids of W7 and its derivatives (10, 28). 
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FIGURE 5 Growth of sensitive and resistant hybrids in dex, The 
hybrid constructed from the fusion of SAK cells with the W7 cell 
line containing wild type receptor (X) as well as one dex' derivative 
(O) of the dex s hybrid (receptor assays for both shown in Fig. 2) 
were grown in 10 -s M dex, and living cells were determined by 
trypan blue exclusion. 
I0 dex s hybrid 
FIGURE 6 Segregation of 
the 'T' function. Meta- 
phase spreads were pre- 
pared as described (4) and 
the chromosomes in the 
dex s hybrid (A) and the 
dex r derivative (B) were 
cou nted. 
o~ 
o 
I' dex r der ivat ive  
(4r+/21 + 21-) ~ (4r+/21 -) 
dex sensitive dex resistant NO. OF CHROMOSOMES 
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Activation of the Lysis Locus 
We have shown that the SAK cell line contains functional 
glucocorticoid receptor and is resistant to lysis by dex due to a 
deficiency in the "lysis" function. The origin of dex resistance 
in SAK could be a mutation in gene(s) encoding the lysis 
function or the inactivation of the lysis gene(s) through a 
process uch as differentiation. In vivo, mature immunocom- 
petent T-cells are resistant to lysis by glucocorticoids; it seems 
possible that SAK might be an example of this more mature 
dex-resistant T-cell type. If this were the case, one might be 
able to activate the expression of the "lysis" gene(s) in these 
ceils. To distinguish between these possibilities, we have em- 
ployed a technique previously shown to activate silent genes. 
Recently, a large amount of work from a number of labo- 
ratories has established a correlation between hypomethylation 
of DNA and expression of specific genes (reviewed in reference 
30). The drug 5-azacytidine inhibits DNA methylation and has 
been shown to cause heritable changes in gene expression i  a 
variety of cell lines (26, 31-33). We treated SAK8 ceils with 5- 
azacytidine, allowed them to recover, and subcloned the pop- 
ulation (as described in Materials and Methods). Since the 
incorporation of 5-azacytidine into DNA is thought to be 
random, it is important o screen for clones expressing the 
specific function under investigation. 
The subclones were tested for sensitivity to glucocorticoids 
and at least 10% of the individual clones tested were lysed by 
dex. The frequency of dex-sensitive clones was always high but 
varied with the length of the 5-azacytidine treatment and with 
the time after treatment at which the clones were assayed. Fig. 
7 shows the growth of SAK8 (Fig. 7A) and one such dex- 
sensitive clone derived by treatment of SAK8 with 5-azacyti- 
dine (Fig. 7B) in the presence and absence of 10 -7 M dex. 
Thus, it is possible to "activate" the lysis function in SAK8 
ceils by treatment with 5-azacytidine. To demonstrate hat the 
dex-sensitive subclones did not pre-exist in the SAK8 popula- 
tion, SAK8 ceils were subcloned and 100 independent clones 
were assayed for response to glucocorticoids. All 100 clones 
were dex-resistant. The high frequency at which dex-sensitive 
iAAK8untreoted s x  
- 106 
"~ 105( :I 
o 2'o 
aBzac treat~lclone x S 
/ 
60 ~; 20 eo 
TIME (hours) 
FIGURE 7 5-azacytidine treatment of SAK8 cells. SAK8 cells were 
treated with 3 #M 5-azacytidine for 13 h, allowed to recover, and 
subcloned as described in Materials and Methods. (A) Untreated 
SAK8 cells grown in the absence (X) and presence (O) of 10 -7 M 
dex. (B) One subclone characterized after azacytidine treatment of 
SAK8 grown in the absence (X) and presence (O) of 10 -7 M dex. 
Living cells were determined by trypan blue exclusion. The dotted 
line (B) indicates that no living cells were detected; the limit of 
detection is 2.2 x 10 3 cells/ml. 
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clones are generated after 5-azacytidine treatment must be as 
a result of the action of the drug on SAK8 cells. 
The generation of dex-sensitive subclones of SAK8 through 
demethylation of DNA supports the hypothesis that the ab- 
sence of the lysis function in SAK8 is not due to a mutation; 
it appears that the necessary genetic material is "intact" in 
SAK8 but inactivated through DNA methylation. These results 
extend our genetic studies howing that the recessive absence 
of the "lysis" function in SAK is complemented by functional 
lysis locus or loci in W7 ceils. 
DISCUSSION 
To date, the hundreds of dex-resistant derivatives obtained 
from the murine T-cell lines $49 and W7, as well as the human 
CEM-C7 line, have been shown to be the result of defects in 
the glucocorticoid receptor (reviewed in references 5 and 7). 
Two general types of receptor defects have been characterized: 
(a) defects in receptor quantity and (b) defects in receptor 
quality, such as nuclear transfer defective. Somatic ell hybrids 
have been used to demonstrate hat a receptor defect of one 
type is not complemented bya different ype of receptor defect 
(8, 10). These data are in agreement with recent work showing 
that a single purified polypeptide is capable of binding both 
glucocorticoid hormones and specific DNA sequences (34). 
There is no evidence that more than a single protein molecule 
is required to bind glucocorticoid hormones and elicit a bio- 
logical response. 
SAK cells are resistant to glucocorticoids in spite of the fact 
that by both biological and biochemical criteria they contain 
functional receptor. Glucocorticoid hormones have specific 
effects on the growth of SAK cells, as well as on the accumu- 
lation of metallothionein a d MuLV mRNAs. The increase in 
MuLV mRNA by glucocorticoids has not been reported pre- 
viously. 
The studies described here provide the first genetic evidence 
for a function, other than the glucocorticoid receptor, involved 
in the cytolytic response. The glucocorticoid receptor of the 
SAK cell line complements the receptor-defective W7 line, 
resulting in a dex-sensitive hybrid. No increase over the sum of 
the parental hormone binding sites is seen in the hybrid, which 
rules out an "activation" of the defective receptor of W7. 
Therefore, the basis for glucocorticoid resistance in SAK cells 
must be in another function which may be determined by a 
single genetic locus or several loci. 
The hybrid between the dex-resistant SAK cells and the dex- 
sensitive W7 cell line is dex sensitive. In this fusion the dex- 
resistant phenotype is recessive. If SAK cells are not resistant 
due to a defect in the lysis function and instead produce a 
substance that "protects" the ceils from lysis, one would have 
expected the resistant phenotype to be dominant unless this 
substance is present in limiting amounts such that it is not 
produced in a sufficient quantity to "protect" a tetraploid cell. 
This possibility seems unlikely since it is possible to "activate" 
the lysis function in SAK8 by treatment with 5-azacytidine. 
Although one could argue that 5-azacytidine activates an in- 
hibitor of the "protecting" substance, this is a much more 
complicated model introducing additional and speculative as- 
sumptions. 
We have used two different hybrids, one diploid and the 
other tetraploid for the receptor locus, to select dex-resistant 
derivatives. It is possible to generate resistance through the loss 
of receptor as well as through the loss of nonreceptor genetic 
material involved in the lysis response, depending on the ploidy 
of the receptor locus. The hybrid tetraploid for the receptor 
locus became dex-resistant through the segregation ofonly two 
chromosomes, on the average, without loss of receptor. We are 
currently constructing imerspecies hybrids to perform similar 
experiments designed to map the "lysis" gene(s) to a specific 
chromosome. 
It is interesting to examine the means by which SAK8 cells 
may have acquired glucocorticoid resistance. We used 5-aza- 
cytidine to inhibit DNA methylation i  SAK8 cells and gen- 
erated ex-sensitive d rivatives. Work from several laboratories 
has demonstrated that thymidine kinase (33), viral (35), and 
metallothionein genes (26) can be activated by treatment of 
cells with 5-azacytidine. It appears, therefore, that the SAK 
line is derived from a mature dex-resistant thymocyte and that, 
during differentiation, onreceptor gene(s) involved in the lytic 
response is/are inactivated through methylation of specific 
DNA sites. If so, immature thymocytes may become resistant 
to glucocorticoids through the inactivation of nonreceptor 
genes involved in the lytic response; the glucocorticoid receptor 
would still be expressed and capable of mediating other effects 
of glucocorticoid hormones on the metabolic processes of these 
cells. The type of glucocorticoid resistance attained by meth- 
ylation of DNA would have an epigenetic origin since it would 
involve a modification rather than a change in the base se- 
quence of the DNA. In contrast, the variety of receptor-defec- 
tive variants generated from W7 and $49 cell lines by muta- 
genic treatments (5) appear to be the result of rare genetic 
(mutational) events. 
The demonstration of a function other than the glucocorti- 
cold receptor involved in cytolysis raises several questions 
about he nature of this "lysis" function. It is certainly possible 
that hormone-induced cell death is the result of a cascade of 
events, only one of which needs to be inactive to generate 
resistance such as that seen in SAK cells. It may be possible, in 
the future, to identify defects in several loci, any one of which 
is sufficient o confer glucocorticoid resistance. Clearly, in the 
case of SAK cells, the "defect" resulting in dex resistance 
cannot be in a vital function since one would expect such a 
defect o be lethal. Finally, it remains to be determined whether 
the "lysis" genes are induced directly by dex or indirectly by 
means of one or several protein intermediates. Another possi- 
bility is that the glucocorticoid hormone receptor interacts with 
a constitutively expressed "acceptor" protein specifically re- 
quired for the lytic response, and that the two proteins together 
are required to induce the cytolysis. In that case, this "acceptor" 
would be the "lysis" function absent in SAK8 cells. 
It is certainly of interest o determine whether a "lysis" 
function is also involved in the lytic response of human T-cell 
lines, and whether this epigenetic mode of the acquisition of 
resistance also applies to human T-cell maturation. These 
questions are currently being examined in human cell lines and 
could have implications in the treatment of human leukemias 
and lymphomas. 
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